⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AUR News
Aurora Innovation, Inc. Class A Common Stock
Aurigene Oncology anuncia los prometedores resultados iniciales de los dos primeros cohortes del estudio de fase 1 de AUR112, un inhibidor oral de MALT1 de molécula pequeña, en neoplasias linfoides recidivadas o refractarias
businesswire.com
AUR
Aurora Expands Driverless Trucking Service from Fort Worth to El Paso
businesswire.com
AUR
AUR
Autonomous Military Weapon Market Forecasted to Reach $36.5 Billion By 2033 Pushing the Boundaries of Traditional Defense
prnewswire.com
VWAV
BBAI
PONY
AUR
DRS
VWAV
BBAI
PONY
AUR
DRS